When did STERIS report Q3 2026 earnings?

STERIS (STE) reported Q3 2026 earnings on February 4, 2026 after market close.

What were STERIS's Q3 2026 revenue and EPS?

STERIS reported revenue of $1.5B and diluted EPS of $2.53 for Q3 2026.

Did STERIS beat estimates in Q3 2026?

Revenue beat the consensus estimate of $1.5B by $15.3M. EPS beat the consensus estimate of $2.53 by $0.00.

How did STERIS's Q3 2026 results compare year-over-year?

Compared to the same quarter a year prior, revenue grew 9.2% from $1.4B a year earlier and diluted EPS grew 9.1% from $2.32.

Where can I find STERIS's Q3 2026 SEC filings?

You can read the 8-K earnings release (0001628280-26-005473) and the 10-Q periodic report (0001628280-26-006055) directly on SEC EDGAR. The filing index links above go to sec.gov.

STERIS STE Q3 2026 earnings

Reported February 4, 2026 · After market close

Revenue$1.5BBeat by $15.3M Diluted EPS$2.53In line

Revenue estimate$1.5B

EPS estimate$2.53

Next report

Aug 5, 2026 (In 1 week)

Revenue estimate$1.5B

EPS estimate$2.54

Financials

Q3 2026

Income statement

See full

Revenue$1.5B+9.2%

Gross profit$655.5M+7.4%

Operating income$273.2M+11.4%

Net income$192.9M+11.2%

EPS (diluted)$1.96+12.0%

Balance sheet

See full

Cash & equivalents$423.7M+173%

Total debt$1.9B-16.7%

Total equity$7.2B+11.5%

Total assets$10.6B+5.8%

Cash flow

See full

Operating cash flow$298.2M-10.4%

CapEx$98.7M+10.7%

Free cash flow$199.5M-18.1%

Valuation & ratios

Valuation

as of 12/31/25

See full

Market cap$24.88B+22.6%

Enterprise value$26.39B+17.5%

P/E35.2×-8.2×

P/S4.3×+0.5×

Profitability

See full

Gross margin44.1%+0.7pp

Operating margin17.2%+1.0pp

Net margin12.1%+3.5pp

FCF margin15.7%+1.8pp

Returns & leverage

See full

Return on equity10.4%+3.1pp

Debt / equity0.3×-0.1×

Current ratio2.5×+0.3×

Segments

By segment

See full

Healthcare Segment$1.1B—

AST$286.6M+11.0%

Life Sciences:$145.8M—

By product

See full

Service$717.6M+9.9%

Consumables$463.0M+8.5%

Capital equipment$315.6M+8.5%

Versus estimates

Revenue

Q4 2026$1.6BMiss by $6.2M

Q3 2026$1.5BBeat by $15.3M

Q2 2026$1.5BBeat by $28.9M Q1 2026$1.4BBeat by $28.4M Q4 2025$1.5BBeat by $11.5M Q3 2025$1.4BMiss by $11.3M

Diluted EPS

Q4 2026$2.83Miss by $0.03

Q3 2026$2.53In line

Q2 2026$2.47Beat by $0.12 Q1 2026$2.34Beat by $0.08 Q4 2025$2.74Beat by $0.14 Q3 2025$2.32Miss by $0.01

Ask the moment STERIS reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI

Claude

Questions, answered.

When did STERIS report Q3 2026 earnings?: STERIS (STE) reported Q3 2026 earnings on February 4, 2026 after market close.
What were STERIS's Q3 2026 revenue and EPS?: STERIS reported revenue of $1.5B and diluted EPS of $2.53 for Q3 2026.
Did STERIS beat estimates in Q3 2026?: Revenue beat the consensus estimate of $1.5B by $15.3M. EPS beat the consensus estimate of $2.53 by $0.00.
How did STERIS's Q3 2026 results compare year-over-year?: Compared to the same quarter a year prior, revenue grew 9.2% from $1.4B a year earlier and diluted EPS grew 9.1% from $2.32.
Where can I find STERIS's Q3 2026 SEC filings?: You can read the 8-K earnings release (0001628280-26-005473) and the 10-Q periodic report (0001628280-26-006055) directly on SEC EDGAR. The filing index links above go to sec.gov.